OA08099A - Compositions and method for protecting T lymphocytes against the etiologic agent of lymphadenopathies and acquired immunosuppression syndrome. - Google Patents

Compositions and method for protecting T lymphocytes against the etiologic agent of lymphadenopathies and acquired immunosuppression syndrome.

Info

Publication number
OA08099A
OA08099A OA58679A OA58679A OA08099A OA 08099 A OA08099 A OA 08099A OA 58679 A OA58679 A OA 58679A OA 58679 A OA58679 A OA 58679A OA 08099 A OA08099 A OA 08099A
Authority
OA
OAPI
Prior art keywords
lymphadenopathies
protecting
compositions
lymphocytes against
etiologic agent
Prior art date
Application number
OA58679A
Other languages
French (fr)
Inventor
David Klatzmann
Jean-Claude Gluckman
Luc Montagnier
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Univ Paris
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient, Univ Paris, Univ Paris Curie filed Critical Pasteur Institut
Publication of OA08099A publication Critical patent/OA08099A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a composition intended for therapeutic use for preventing or combating infection, mainly in vivo, of T lymphocytes by LAV viruses. This composition contains, as active principle, anti-T4 antibodies, free or coupled covalently to an antiviral agent.
OA58679A 1984-09-14 1985-09-16 Compositions and method for protecting T lymphocytes against the etiologic agent of lymphadenopathies and acquired immunosuppression syndrome. OA08099A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8414172A FR2570278B1 (en) 1984-09-14 1984-09-14 COMPOSITIONS AND METHOD FOR PROTECTING T CELLS FROM THE ETIOLOGICAL AGENT OF LYMPHADENOPATHIES AND ACQUIRED IMMUNODEPRESSION SYNDROME

Publications (1)

Publication Number Publication Date
OA08099A true OA08099A (en) 1987-03-31

Family

ID=9307750

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58679A OA08099A (en) 1984-09-14 1985-09-16 Compositions and method for protecting T lymphocytes against the etiologic agent of lymphadenopathies and acquired immunosuppression syndrome.

Country Status (8)

Country Link
EP (1) EP0176429B1 (en)
JP (2) JP2783403B2 (en)
AT (1) ATE58478T1 (en)
CA (1) CA1273304A (en)
DE (2) DE3583400D1 (en)
ES (1) ES8608884A1 (en)
FR (1) FR2570278B1 (en)
OA (1) OA08099A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2592893A1 (en) * 1986-01-15 1987-07-17 Pasteur Institut POPULATION OF LAV VIRUS SPECIFIC T4 LYMPHOCYTES, THEIR PROCESS FOR OBTAINING IT AND THEIR APPLICATION TO THE PRODUCTION OF THIS VIRUS.
IL83687A (en) * 1987-08-30 1995-03-30 Yeda Res & Dev Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions
WO1989004672A1 (en) * 1987-11-20 1989-06-01 The Upjohn Company Derivatives of lincosaminide antibiotics
ATE85215T1 (en) * 1987-12-19 1993-02-15 Experimentelle Chirurgie Lab ANTIVIRAL THERAPEUTIC.
DE3828582A1 (en) * 1988-08-23 1990-03-01 Max Planck Gesellschaft MONOCLONAL ANTIBODY TO INHIBIT THE INFECTION OF CELLS BY HIV VIRUSES
EP0408372A1 (en) * 1989-07-13 1991-01-16 Smithkline Beecham Corporation Anti-viral therapy
US5591448A (en) * 1994-11-21 1997-01-07 Tepic; Slobodan Anti-viral therapeutic composition
RU2121852C1 (en) * 1997-12-25 1998-11-20 Акционерное общество закрытого типа "Научно-производственное предприятие "Олифен" Composition optimizing cell vital activity and the host cellular systems under unfavorable conditions
RU2208442C1 (en) * 2002-04-22 2003-07-20 Восточно-Сибирский государственный технологический университет Complex immunocorrecting agent
CN106075626B (en) * 2016-07-01 2018-06-26 浙江大学 A kind of AIDS blood purifying therapeutical instrument
CN106166313B (en) * 2016-07-01 2018-09-07 浙江大学 A kind of AIDS pregnant woman blood clarifier

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381295A (en) * 1979-04-26 1983-04-26 Ortho Pharmaceutical Corporation Monoclonal antibody to human helper T cells and methods of preparing same
FR2504010B1 (en) * 1981-04-15 1985-10-25 Sanofi Sa ANTI-CANCER MEDICINAL PRODUCTS CONTAINING THE RICIN-ASSOCIATED CHAIN ASSOCIATED WITH ANTIMELANOMA ANTIBODY AND PROCESS FOR THEIR PREPARATION

Also Published As

Publication number Publication date
DE3580639D1 (en) 1991-01-03
ATE58478T1 (en) 1990-12-15
EP0176429B1 (en) 1990-11-22
ES546974A0 (en) 1986-09-01
JP2783403B2 (en) 1998-08-06
JPH0912462A (en) 1997-01-14
JPS61143328A (en) 1986-07-01
FR2570278B1 (en) 1987-02-13
ES8608884A1 (en) 1986-09-01
EP0176429A1 (en) 1986-04-02
FR2570278A1 (en) 1986-03-21
DE3583400D1 (en) 1991-08-08
CA1273304A (en) 1990-08-28

Similar Documents

Publication Publication Date Title
EA199800357A1 (en) PHARMACEUTICAL ANGIOSTATIC DIPEPTIDE COMPOSITIONS AND METHODS OF THEIR APPLICATION
BG91270A (en) ANTIVIRAL AND ANTIBACTERIAL AGENT AND METHOD OF ITS USE
PT80303B (en) PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR BUCAL HYGIENE
EP0219876A3 (en) Antihypertensive agents comprising 2-alkynyladenosines as active ingredients
IL99145A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
GR78512B (en)
KR960701049A (en) Heterocyclic compounds and their preparation and use
DK0544714T3 (en) Heterocyclic compounds and their preparation and use
OA08099A (en) Compositions and method for protecting T lymphocytes against the etiologic agent of lymphadenopathies and acquired immunosuppression syndrome.
ES8506730A1 (en) New cephem compounds and processes for preparation thereof.
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
OA07525A (en) Amino-acid derivatives, their preparation and use as well as the compositions containing these derivatives.
NZ222045A (en) From diamides up to tetrapeptides for use as anticanvulsants
OA07270A (en) N- (vinblastinoyl-23) amino acid derivatives, their preparation and therapeutic application.
ATE22282T1 (en) PENTACYCLOUNDECAN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2701952B1 (en) New cyclopeptide derivatives of angiopeptin, their preparation process and the pharmaceutical compositions containing them.
EP0335426A3 (en) Compositions and process for protecting t lymphocytes against the etiological agent of lymphadenopathy and acquired immunodepression syndrom
IT8125895A0 (en) TETRAHYDRO-1,2,4-OXADIAZIN-5-ONE SUBSTITUTED DERIVATIVES HAVING ANTI CONVULSIVE ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IT8221552A0 (en) NEW COMPOUNDS WITH ANTI-NEOPLASTIC ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
IE810008L (en) Iodinated propionitrile
IT1198378B (en) HYDROXYMINIC AND ALCOXYMINIC COMPOUNDS WITH CALCIUMANATAGONIST ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
DE3885978D1 (en) Cephem compounds and processes for their preparation.
IT8219176A0 (en) COMPOUNDS WITH NOOTROPIC, ANTI-ASTHENICA AND ANTI-ULCERA ACTIVITIES, PROCESS FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
IT8320672A0 (en) NEW COMPOUNDS WITH ANTI-NEOPLASTIC ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
IT1132203B (en) NITROGEN ISOPRENOID COMPOUNDS FOR THERAPEUTIC ACTIVITIES, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC COMPOSITIONS